Steven L Knapp

Title: Innovations in Ovarian Cancer Detection by Steven L. Knapp

Introduction

Steven L. Knapp is an accomplished inventor based in Apex, North Carolina. He has made significant contributions to the field of medical diagnostics, particularly in the detection of ovarian cancer. With a total of two patents to his name, his work focuses on innovative methods and compositions that enhance the diagnosis of this critical health issue.

Latest Patents

One of Steven L. Knapp's latest patents is centered around glycodelin monoclonal antibodies and their applications in diagnosing ovarian cancer. This invention provides compositions and methods for identifying patients who may have an increased likelihood of ovarian cancer. The compositions include novel monoclonal antibodies, as well as their variants and fragments, that specifically bind to glycodelin. Additionally, the patent discloses hybridoma cell lines that produce these antibodies, along with kits designed for practicing the methods of the invention. The polypeptides that comprise the amino acid sequence for a glycodelin epitope are also included, showcasing the comprehensive nature of his research.

Career Highlights

Steven L. Knapp is currently associated with Tripath Imaging, Inc., where he continues to advance his research in medical diagnostics. His work has been pivotal in developing tools that aid in the early detection of ovarian cancer, which is crucial for improving patient outcomes.

Collaborations

Some of his notable coworkers include Robert L. Cheek and Eric P. Dixon. Their collaborative efforts contribute to the innovative environment at Tripath Imaging, Inc., fostering advancements in cancer diagnostics.

Conclusion

Steven L. Knapp's contributions to the field of ovarian cancer detection through his innovative patents highlight the importance of research in medical diagnostics. His work not only enhances the understanding of ovarian cancer but also provides essential tools for early detection and diagnosis.